Rapid communication Open Access
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.41.17-00645
Like 0
Access full text
Article
-
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
- Marc Rondy1 , Alin Gherasim2,3 , Itziar Casado3,4 , Odile Launay5,6 , Caterina Rizzo7 , Daniela Pitigoi8 , Aukse Mickiene9 , Sierk D Marbus10 , Ausenda Machado11 , Ritva K Syrjänen12 , Iva Pem-Novose13 , Judith Krisztina Horváth14 , Amparo Larrauri2,3 , Jesús Castilla3,4 , Philippe Vanhems5,15,16 , Valeria Alfonsi7 , Alina E Ivanciuc17 , Monika Kuliese9 , Rianne van Gageldonk-Lafeber10 , Veronica Gomez11 , Niina Ikonen18 , Zvjezdana Lovric13 , Annamária Ferenczi14 , I-MOVE+ hospital working group19 , Alain Moren1
-
View Affiliations Hide AffiliationsAffiliations: 1 EpiConcept, Paris, France 2 National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain 3 CIBER Epidemiología y Salud Pública, Institute of Health Carlos III, Madrid, Spain 4 Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain 5 Inserm, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), CIC 1417, Paris, France 6 Université Paris Descartes, Sorbonne Paris Cité, APHP, CIC Cochin-Pasteur, Paris, France 7 Istituto Superiore di Sanità, Rome, Italy 8 University of Medicine and Pharmacy Carol Davila, National Institute for Research Cantacuzino, Bucharest, Romania 9 Department of Infectious diseases of Lithuanian University of Health Sciences, Kaunas, Lithuania 10 Centre for Epidemiology and surveillance of infectious diseases, Centre for Infectious disease control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 11 Epidemiology Research Unit, Epidemiology Department, National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal 12 Impact Assessment Unit, National Institute for Health and Welfare, Tampere, Finland 13 Epidemiology Service, Croatian Institute of Public Health, Zagreb, Croatia 14 Office of the Chief Medical Officer, Budapest, Hungary 15 Infection Control and Epidemiology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France 16 Emerging Pathogens Laboratory - Fondation Mérieux, Centre International de Recherche en Infectiologie, INSERM U1111, Centre National de la Recherche Scientifique (CNRS), UMR5308, Ecole Nationale Supérieure (ENS) de Lyon, Université Claude Bernard Lyon 1, Lyon, France; 17 National Institute for Research Cantacuzino, Bucharest, Romania, Faculty of Biology, Bucharest University 18 Unit of Expert Microbiology, National Institute for Health and Welfare, Helsinki, Finland 19 The members of the I-Move+ hospital working group are listed at the end of the articleCorrespondence:Marc Rondym.rondy epiconcept.fr
-
View Citation Hide Citation
Citation style for this article: Rondy Marc, Gherasim Alin, Casado Itziar, Launay Odile, Rizzo Caterina, Pitigoi Daniela, Mickiene Aukse, Marbus Sierk D, Machado Ausenda, Syrjänen Ritva K, Pem-Novose Iva, Horváth Judith Krisztina, Larrauri Amparo, Castilla Jesús, Vanhems Philippe, Alfonsi Valeria, Ivanciuc Alina E, Kuliese Monika, van Gageldonk-Lafeber Rianne, Gomez Veronica, Ikonen Niina, Lovric Zvjezdana, Ferenczi Annamária, I-MOVE+ hospital working group, Moren Alain. Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season. Euro Surveill. 2017;22(41):pii=17-00645. https://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645 Received: 18 Sept 2017; Accepted: 12 Oct 2017
Abstract
In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65–79-year-olds and 13% (95% CI: −15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.
Article metrics loading...
/content/10.2807/1560-7917.ES.2017.22.41.17-00645
2017-10-12
2024-11-02
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.41.17-00645
Full text loading...
/deliver/fulltext/eurosurveillance/22/41/eurosurv-22-41-2.html?itemId=/content/10.2807/1560-7917.ES.2017.22.41.17-00645&mimeType=html&fmt=ahah
References
-
European Centre for Disease Prevention and Control (ECDC) / World Health Organization Regional Office for Europe (WHO/Europe). Joint ECDC-WHO/Europe weekly influenza update - Week 20/2017 (15 – 21 May 2017). ECDC-WHO/Europe. [Accessed 20 Jun 2017]. Available from: https://flunewseurope.org/Archives
-
European Centre for Disease Prevention and Control (ECDC). Risk assessment of seasonal influenza, EU/EEA, 2016-2017 - Update. Stockholm: ECDC; 25 Jan 2017. Available from: http://ecdc.europa.eu/en/publications/Publications/Risk-assessment-seasonal-influenza-2016-2017-update.pdf
-
Kissling E, Rondy MI-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017;22(7):30464. . https://doi.org/10.2807/1560-7917.ES.2017.22.7.30464 PMID: 28230524
-
Integrated Monitoring of Vaccines in Europe plus (I-MOVE+). [Internet]. [Accessed 10 October 2017]. Available from: http://www.i-moveplus.eu/wp2
-
Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O, et al. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project. Euro Surveill. 2017;22(30):30580. https://doi.org/10.2807/1560-7917.ES.2017.22.30.30580 PMID: 28797322
-
McNeil SA, Andrew MK, Ye L, Haguinet F, Hatchette TF, ElSherif M, et al. Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015. Euro Surveill. 2015;20(5):21024. https://doi.org/10.2807/1560-7917.ES2015.20.5.21024 PMID: 25677052
-
Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador FX, Belenguer-Varea A, Carballido-Fernandez M, et al. Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. Euro Surveill. 2015;20(8):21044. https://doi.org/10.2807/1560-7917.ES2015.20.8.21044 PMID: 25742432
-
Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. PLoS One. 2013;8(4):e59681. https://doi.org/10.1371/journal.pone.0059681 PMID: 23565159
-
Rondy M, El Omeiri N, Thompson MG, Levêque A, Moren A, Sullivan SG. Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies. J Infect. 2017;•••:S0163-4453(17)30299-2.; Epub ahead of print. https://doi.org/10.1016/j.jinf.2017.09.010 PMID: 28935236
-
Melidou A, Broberg EEuropean region influenza surveillance network. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18. Vaccine. 2017;35(37):4828-35. https://doi.org/10.1016/j.vaccine.2017.07.057 PMID: 28780977
-
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza season. Geneva: WHO; 1 Mar 2017. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2017_18_north/en/
-
World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season. Geneva: WHO; 28 Sep 2017. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/2018_south/en/
-
World Health Organization (WHO). Influenza Update N°299. Geneva: WHO; 2 Oct 2017. Available from: http://www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
<p class="citation">
<span>Citation style for this article:</span>
<span class="meta-value authors">
<a href="/search?value1=Marc+Rondy&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rondy Marc</a>,
<a href="/search?value1=Alin+Gherasim&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gherasim Alin</a>,
<a href="/search?value1=Itziar+Casado&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Casado Itziar</a>,
<a href="/search?value1=Odile+Launay&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Launay Odile</a>,
<a href="/search?value1=Caterina+Rizzo&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Rizzo Caterina</a>,
<a href="/search?value1=Daniela+Pitigoi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pitigoi Daniela</a>,
<a href="/search?value1=Aukse+Mickiene&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mickiene Aukse</a>,
<a href="/search?value1=Sierk+D+Marbus&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Marbus Sierk D</a>,
<a href="/search?value1=Ausenda+Machado&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Machado Ausenda</a>,
<a href="/search?value1=Ritva+K+Syrj%C3%A4nen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Syrjänen Ritva K</a>,
<a href="/search?value1=Iva+Pem-Novose&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pem-Novose Iva</a>,
<a href="/search?value1=Judith+Krisztina+Horv%C3%A1th&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Horváth Judith Krisztina</a>,
<a href="/search?value1=Amparo+Larrauri&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Larrauri Amparo</a>,
<a href="/search?value1=Jes%C3%BAs+Castilla&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Castilla Jesús</a>,
<a href="/search?value1=Philippe+Vanhems&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vanhems Philippe</a>,
<a href="/search?value1=Valeria+Alfonsi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Alfonsi Valeria</a>,
<a href="/search?value1=Alina+E+Ivanciuc&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ivanciuc Alina E</a>,
<a href="/search?value1=Monika+Kuliese&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kuliese Monika</a>,
<a href="/search?value1=Rianne+van+Gageldonk-Lafeber&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Gageldonk-Lafeber Rianne</a>,
<a href="/search?value1=Veronica+Gomez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gomez Veronica</a>,
<a href="/search?value1=Niina+Ikonen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ikonen Niina</a>,
<a href="/search?value1=Zvjezdana+Lovric&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lovric Zvjezdana</a>,
<a href="/search?value1=Annam%C3%A1ria+Ferenczi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ferenczi Annamária</a>,
<a href="/search?value1=I-MOVE%2B+hospital+working+group&option1=author&noRedirect=true" class="nonDisambigAuthorLink">I-MOVE+ hospital working group</a>,
<a href="/search?value1=Alain+Moren&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Moren Alain</a></span>.
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.
<a href="/content/ecdc">Euro Surveill.</a> 2017;22(41):pii=17-00645.
<a href="https://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645</a>
<span class="ES_Article_citation">
<span class="generated">Received</span>: 18 Sept 2017;
<span class="generated">Accepted</span>: 12 Oct 2017
</span>
</p>
/content/10.2807/1560-7917.ES.2017.22.41.17-00645
/content/10.2807/1560-7917.ES.2017.22.41.17-00645
Data & Media loading...
Submit comment
Close
Comment moderation successfully completed